Nachrichten: Business Wire (engl.)

    Regulatory News: OSE Pharma SA (Paris:OSE) (ISIN: FR0012127173; Mnémo: OSE), a biotechnology company based in France, developing T specific immunotherapy treatments against invasive and metastatic cancers, is …

    Themen: EuroUSAFranc

    Regulatory News: Highlights during the report period · The work on the Pre-feasibility study (“PFS”) relating to the Rönnbäcken nickel project (“RNP”) continued during the first quarter of …

    Wertpapier: Nickel Moun

    Themen: SEKNickel
    ZeitTitel
    07:30 
    06:01 
    06:01 
    05:54 
    05:41 
    05:13 
    04:42 
    04:32 
    04:15 
    04:00 
    04:00 
    01:34 
    01:22 
    01:00 
    00:52 
    00:48 
    00:42 
    00:41 
    00:29 
    00:16 
    00:01 
    00:00 
    27.05.
    27.05.
    27.05.

    Nachrichtenquelle

    Weitere Nachrichten des Autors

    TitelLeser
    310
    289
    265
    233
    223
    217
    217
    215
    214
    211
    TitelLeser
    978
    781
    637
    613
    609
    570
    543
    542
    537
    488
    TitelLeser
    1155
    1084
    1048
    978
    978
    935
    872
    830
    784
    781
    TitelLeser
    15405
    9663
    9400
    8752
    8392
    8168
    7739
    7459
    7178
    7164